Long-Delayed Drug-Price Legislation Not Dead Yet, Grassley Says

June 1, 2020, 9:13 PM UTC

Senate Finance Committee Chairman Chuck Grassley said that he intends to push for a vote this year on a bill that would limit drug-price increases, even as pharmaceutical companies race to find treatments and vaccines for Covid-19.

The drug industry has been pouring resources into researching new therapies as the pandemic wreaks havoc on Americans’ health and the country’s economy. That has helped quiet a long-running debate over rising prescription costs, as policy makers prioritize finding treatments and helping businesses safely re-open.

“There’s no better time to address this issue,” said Grassley, an Iowa Republican and a co-sponsor of the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.